Professional Documents
Culture Documents
Midazolam
Allison B. Hensley, RN
Abstract
Midazolam
Premedication in pediatric patients has been proven successful in decreasing anxiety prior
to any procedure involving anesthesia (Keles & Kocaturk, 2018). While preoperative
cooperation is necessary, decreasing emergence agitation is also important. For this literature
used premedication among pediatric patients undergoing dental anesthesia procedures. However,
some disadvantages observed with this medication include respiratory depression, a lack of
analgesic effect, and negative postoperative behavior (Sajid, Mohamed, & Jumaila, 2019). As a
nurse in a dental office, my role involves assisting our dental anesthesiologist (DA), as well as
our certified registered nurse anesthetist (CRNA) in caring for pediatric patients both
is crucial in generating positive patient outcomes, with a common aim to provide current best
midazolam.
Population
For this review we will be focusing on the pediatric population between 1 and 12 years of
age. Within this age range, approximately 50 percent of patients present with significant
preoperative apprehension and fear (Jannu, Mane, Dhorigol, & Sanikop, 2016). According to
Sajid, Mohamed and Jumaila (2019), the percentage is even higher at 60%-70%. An increase in
anxiety occurs once they are separated from their parent(s) or family members. Emergence
agitation (EA) is also a common issue among this population, which include behaviors such as
PREMEDICATIONS IN PEDIATRIC 4
thrashing, kicking, and uncontrollable crying. The child may wake up experiencing
hallucinations and disorientation, which may lead to additional nursing care, and a delayed
discharge from recovery (Keles & Kocaturk, 2018). In instances such as these, pharmacologic
agents may be indicated and used as premedications in order to assist in child-parent separation,
and promote a smooth induction of anesthesia ( Chatrath, Kumar, Sachdeva, & Thakur, 2018).
Intervention
The use of dexmedetomidine as a premedication for pediatric procedures has been on the
anti-anxiety properties, with minimal respiratory depression ( Mohite, Baliga, Thosar, & Rathi,
2019). In addition, dexmedetomidine has been found to reduce the severity of EA among
children, making the overall experience less frightening for both the patient and family (Sajid et
al., 2019). This can be linked to the longer duration of dexmedetomidine, in that this
premedication lasts the duration of the procedure, aiding in a calm postoperative period (Chatrath
et al., 2018). In providing adequate sedation, along with cardiovascular and respiratory stability,
dexmedetomidine is now being preferred over midazolam by many providers (Prabhu &
Mehandale, 2017).
The current practice within our dental office involves the use of oral midazolam as a
premedication prior to dental procedures. While this medication provides reliable sedation and
an amnesic effect for our pediatric patients, it also has it’s disadvantages. These include a bitter
taste when administered orally, a decrease in respirations, a lack of analgesic properties, and
occasionally paradoxical reactions (Keles & Kocaturk, 2018). Patients often refuse or spit out
this premedication when administered orally. While midazolam promotes a smooth induction
PREMEDICATIONS IN PEDIATRIC 5
into anesthesia, it does not seem to have a direct impact on decreasing EA. It has been shown
that effective treatment of post-operative pain has been linked to a reduced incidence of EA
(Prabhu & Mehandale, 2017). Without analgesic effects, patients who are given midazolam as a
premedication are at higher risk for EA, in comparison with dexmedetomidine (Keles &
Kocaturk, 2018).
Outcome
reduces the occurrence of EA and provides better overall analgesic effect. In the dental setting, it
is important to minimize emotional trauma among pediatric patients. Patients who have negative
dental experiences as children have a lower occurrence of maintaining proper oral hygiene and
dental care in adulthood (Mohite et al., 2019). In addition to the advantages of dexmedetomidine,
it has also been linked to a postoperative reduction of nausea and vomiting (Mohite et al., 2019).
It is anticipated that the use of dexmedetomidine as a premedication will generate higher positive
Clinical setting
Pediatric patients who generally have low levels of cooperation during dental visits, also
present with uncooperative behaviors during the preoperative period for dental anesthesia (Keles
& Kocaturk, 2018). Thus, the need for a premedication is necessary for successful dental
procedures. In the past, non-pharmacologic control techniques were used in instances such as
these. These included things such as voice control, restraints and intimidation (Keles &
Kocaturk, 2018). Often, these methods were not therapeutic, and proved inadequate in
completion of required dental treatment. These control techniques are not used within our dental
PREMEDICATIONS IN PEDIATRIC 6
clinic. As a nurse, I aim to provide a positive experience within our office for both the patient
and their families. Recent studies has shown that administering dexmedetomidine as a
practice within my occupation, and advocating for updated changes within the world of
Research question
For the pediatric patient, does the use of dexmedetomidine as a premedication aid in
parental separation, and reduce the future risk of emergence agitation in comparison with
midazolam?
PICO
medication.
lessen separation anxiety from parents and decrease the occurrence of emergence agitation.
PREMEDICATIONS IN PEDIATRIC 7
References
Chatrath, V., Kumar, R., Sachdeva, U., & Thakur, M. (2018). Intranasal Fentanyl,
Jannu, V., Mane, R. S., Dhorigol, M. G., & Sanikop, C. S. (2016). A comparison of oral
Keles, S., & Kocaturk, O. (2018). Comparison of oral dexmedetomidine and midazolam
for premedication and emergence delirium in children after dental procedures under general
https://doi.org/10.2147/DDDT.S163828
Mohite, V., Baliga, S., Thosar, N., & Rathi, N. (2019). Role of dexmedetomidine in
https://doi.org/10.17245/jdapm.2019.19.2.83
5049.199852
Sajid, B., Mohamed, T., & Jumaila, M. (2019). A comparison of oral dexmedetomidine